marketcaparena
Search

    ADMA

    ADMA BIOLOGICS, INC.

    Company overview

    Market capitalization
    $2.27B
    Employees
    640
    Latest publication
    2026-09-29
    About ADMA BIOLOGICS, INC.

    ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company operates through ADMA BioManufacturing and Plasma Collection Centers segments. The company offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB, a human polyclonal antibody product for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It also develops a pipeline of plasma-derived therapeutics comprising products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, the company operates source plasma collection facilities. The company sells its products through independent distributors, drug wholesalers, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Revenue124,395,000USD114,493,000USD139,163,000USD134,224,000USD121,984,000USD114,802,000USD117,549,000USD119,839,000USD
    Cost Of Revenue38,118,000USD33,743,000USD50,347,000USD58,598,000USD54,757,000USD53,705,000USD54,216,000USD60,180,000USD
    Gross Profit86,277,000USD80,750,000USD88,816,000USD75,626,000USD67,227,000USD61,097,000USD63,333,000USD59,659,000USD
    Research Development6,014,000USD2,597,000USD1,376,000USD1,528,000USD1,031,000USD826,000USD391,000USD412,000USD
    Selling General Administrative26,737,000USD26,742,000USD23,512,000USD21,776,000USD22,214,000USD24,079,000USD23,317,000USD18,560,000USD
    Other Operating Expenses1,081,000USD———————
    Total Operating Expenses33,832,000USD30,401,000USD26,065,000USD24,614,000USD24,429,000USD26,216,000USD25,010,000USD20,021,000USD
    Operating Income52,445,000USD50,294,000USD62,751,000USD51,012,000USD42,798,000USD34,881,000USD38,323,000USD39,638,000USD
    Total Other Income Expense Net-2,208,000USD6,833,000USD-1,156,000USD-3,497,000USD-2,701,000USD-1,431,000USD-3,610,000USD-2,889,000USD
    Interest Expense3,424,000USD2,100,000USD1,626,000USD1,675,000USD1,834,000USD1,975,000USD2,879,000USD3,499,000USD
    Income Before Tax50,237,000USD57,127,000USD61,595,000USD47,515,000USD40,097,000USD33,450,000USD34,713,000USD36,749,000USD
    Income Tax Expense12,415,000USD11,799,000USD12,216,000USD11,087,000USD5,878,000USD6,546,000USD-77,183,000USD840,000USD
    Net Income37,822,000USD45,328,000USD49,379,000USD36,428,000USD34,219,000USD26,904,000USD111,896,000USD35,909,000USD
    Unclassified Operating Expenses—1,062,000USD1,177,000USD1,310,000USD1,184,000USD1,311,000USD1,302,000USD1,049,000USD
    Interest Income—1,093,000USD487,000USD376,000USD400,000USD608,000USD598,000USD666,000USD
    Net Interest Income—-1,007,000USD-1,139,000USD-1,299,000USD-1,434,000USD-1,367,000USD-2,281,000USD-2,833,000USD
    Tax Provision—11,799,000USD12,216,000USD11,087,000USD5,878,000USD6,546,000USD-77,183,000USD840,000USD
    Net Income From Continuing Ops—45,328,000USD49,379,000USD36,428,000USD34,219,000USD26,904,000USD111,896,000USD35,909,000USD
    Ebit—59,227,000USD63,221,000USD49,190,000USD41,931,000USD35,425,000USD37,592,000USD40,248,000USD
    Ebitda—61,066,000USD65,267,000USD51,213,000USD43,989,000USD37,394,000USD39,536,000USD42,188,000USD
    Depreciation And Amortization—1,839,000USD2,046,000USD2,023,000USD2,058,000USD1,969,000USD1,944,000USD1,940,000USD
    Reconciled Depreciation—1,839,000USD2,046,000USD2,023,000USD2,058,000USD1,969,000USD1,944,000USD1,940,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20122012-12-31 · USDFY 20112011-12-31 · USDFY 20102010-12-31 · USDFY 20092009-12-31 · USDFY 20082008-12-31 · USDFY 20072007-12-31 · USD
    Total Revenue510,173,000USD426,454,000USD1,118,118USD—————
    Cost Of Revenue217,408,000USD206,901,000USD669,056USD—————
    Gross Profit292,765,000USD219,553,000USD449,062USD—————
    Research Development4,762,000USD1,813,000USD3,469,078USD—————
    Selling General Administrative91,580,000USD74,124,000USD3,142,289USD26,464USD20,530USD20,530USD—24,000USD
    Unclassified Operating Expenses4,980,000USD4,633,000USD1,746,864USD——-20,029,530USD——
    Total Operating Expenses101,322,000USD80,570,000USD8,358,231USD26,464USD20,530USD-20,009,000USD24,916,000USD29,735,000USD
    Operating Income191,443,000USD138,983,000USD-7,909,169USD-26,464USD-20,530USD-20,009,000USD-24,891,000USD-29,687,000USD
    Interest Income1,871,000USD2,097,000USD——————
    Interest Expense7,110,000USD13,930,000USD30,683USD0USD0USD0USD0USD0USD
    Net Interest Income-5,239,000USD-11,833,000USD——————
    Income Before Tax182,656,000USD125,714,000USD-7,918,928USD-26,460USD-20,526USD-20,009,000USD-24,891,000USD-29,687,000USD
    Income Tax Expense35,726,000USD-71,959,000USD-617,615USD-4USD-4USD———
    Tax Provision35,726,000USD-71,959,000USD——————
    Net Income146,930,000USD197,673,000USD-7,301,313USD-26,460USD-20,526USD-20,009,000USD-24,891,000USD-29,687,000USD
    Net Income From Continuing Ops146,930,000USD197,673,000USD-7,301,313USD—————
    Ebit189,766,000USD139,644,000USD-7,888,245USD-26,464USD-20,530USD-20,009,000USD-24,891,000USD-29,687,000USD
    Ebitda197,862,000USD147,689,000USD-7,706,156USD-26,460USD-20,526USD-20,009,000USD-24,891,000USD-29,687,000USD
    Depreciation And Amortization8,096,000USD8,045,000USD182,089USD4USD4USD———
    Reconciled Depreciation8,096,000USD8,045,000USD——————
    Total Other Income Expense Net-8,787,000USD-13,269,000USD-9,759USD4USD4USD———
    Non Operating Income Net Other——20,924USD—————
    Net Income Applicable To Common Shares——-7,301,313USD—————
    Other Operating Expenses———26,464USD20,530USD—24,916,000USD29,735,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets684,210,000USD665,184,000USD624,242,000USD568,687,000USD558,380,000USD510,569,000USD488,678,000USD390,618,000USD
    Cash And Equivalents136,020,000USD———————
    Total Current Assets528,203,000USD511,173,000USD466,512,000USD402,655,000USD399,563,000USD351,814,000USD331,410,000USD318,193,000USD
    Other Current Assets14,639,000USD15,060,000USD13,988,000USD6,930,000USD8,088,000USD8,589,000USD8,029,000USD9,545,000USD
    Total Liabilities276,002,000USD———————
    Total Current Liabilities75,757,000USD73,541,000USD69,541,000USD56,490,000USD74,941,000USD53,498,000USD55,542,000USD44,891,000USD
    Total Stockholder Equity408,208,000USD390,325,000USD477,320,000USD431,186,000USD398,325,000USD373,419,000USD349,018,000USD231,890,000USD
    Total Equity Including Noncontrolling Interest408,208,000USD———————
    Short Long Term Debt3,750,000USD3,281,000USD2,813,000USD2,344,000USD————
    Long Term Debt192,839,000USD193,584,000USD69,330,000USD70,084,000USD73,397,000USD72,527,000USD72,337,000USD101,326,000USD
    Deferred Revenue Non Current1,334,000USD———————
    Net Receivables138,231,000USD135,862,000USD158,429,000USD137,673,000USD109,726,000USD99,412,000USD49,999,000USD50,140,000USD
    Inventory239,313,000USD222,098,000USD206,465,000USD196,667,000USD191,464,000USD172,188,000USD170,235,000USD171,801,000USD
    Property Plant Equipment Net72,810,000USD71,412,000USD71,707,000USD78,780,000USD66,462,000USD65,730,000USD63,341,000USD53,694,000USD
    Goodwill3,530,000USD———————
    Intangible Assets575,000USD630,000USD632,000USD491,000USD527,000USD452,000USD460,000USD485,000USD
    Accounts Payable31,724,000USD20,523,000USD22,519,000USD24,021,000USD29,769,000USD20,607,000USD20,219,000USD16,020,000USD
    Short Term Debt1,178,000USD4,457,000USD3,909,000USD3,642,000USD1,127,000USD1,188,000USD1,218,000USD1,193,000USD
    Common Stock24,000USD24,000USD24,000USD24,000USD24,000USD24,000USD24,000USD24,000USD
    Retained Earnings-78,503,000USD-116,325,000USD-161,653,000USD-211,032,000USD-247,460,000USD-281,679,000USD-308,583,000USD-420,479,000USD
    Total Liab—274,859,000USD146,922,000USD137,501,000USD160,055,000USD137,150,000USD139,660,000USD158,728,000USD
    Other Current Liab—48,561,000USD43,113,000USD28,827,000USD41,202,000USD24,959,000USD30,481,000USD27,535,000USD
    Capital Stock—24,000USD24,000USD24,000USD24,000USD24,000USD24,000USD24,000USD
    Good Will—3,530,000USD3,530,000USD3,530,000USD3,530,000USD3,530,000USD3,530,000USD3,530,000USD
    Cash—138,153,000USD87,630,000USD61,385,000USD90,285,000USD71,625,000USD103,147,000USD86,707,000USD
    Cash And Short Term Investments—138,153,000USD87,630,000USD61,385,000USD90,285,000USD71,625,000USD103,147,000USD86,707,000USD
    Current Deferred Revenue—1,369,000USD1,405,000USD1,440,000USD143,000USD143,000USD143,000USD143,000USD
    Net Debt—66,253,000USD-7,745,000USD21,738,000USD-6,460,000USD10,388,000USD-21,031,000USD24,677,000USD
    Short Long Term Debt Total—204,406,000USD79,885,000USD83,123,000USD83,825,000USD82,013,000USD82,116,000USD111,384,000USD
    Property Plant Equipment Gross—111,407,000USD110,055,000USD78,780,000USD103,984,000USD101,226,000USD96,893,000USD95,042,000USD
    Common Stock Shares Outstanding—239,955,762shares243,854,484shares244,664,263shares248,608,460shares244,676,000shares245,901,000shares244,804,000shares
    Non Current Assets Total—154,011,000USD157,730,000USD166,032,000USD158,817,000USD158,755,000USD157,268,000USD72,425,000USD
    Non Current Liabilities Total—201,318,000USD77,381,000USD81,011,000USD85,114,000USD83,652,000USD84,118,000USD113,837,000USD
    Non Currrent Assets Other—8,470,000USD8,600,000USD8,798,000USD9,063,000USD8,188,000USD5,657,000USD14,716,000USD
    Net Working Capital—437,632,000USD396,971,000USD346,165,000USD324,622,000USD298,316,000USD275,868,000USD273,302,000USD
    Unclassified Non Current Assets—69,969,000USD73,261,000USD74,433,000USD79,235,000USD80,855,000USD84,280,000USD—
    Unclassified Current Liabilities—-4,650,000USD-4,218,000USD-3,784,000USD2,700,000USD6,601,000USD3,481,000USD—
    Unclassified Non Current Liabilities—7,734,000USD8,051,000USD10,837,000USD10,777,000USD9,810,000USD10,108,000USD10,448,000USD
    Unclassified Equity—506,602,000USD638,925,000USD642,170,000USD645,737,000USD655,050,000USD657,553,000USD652,321,000USD
    Non Current Liabilities Other———90,000USD940,000USD1,315,000USD1,673,000USD2,063,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets624,242,000USD488,678,000USD329,182,000USD348,461,000USD276,252,724USD207,673,394USD127,090,725USD88,876,521USD
    Intangible Assets632,000USD460,000USD499,000USD1,013,000USD1,728,768USD2,444,121USD3,159,474USD4,004,412USD
    Other Current Assets13,988,000USD8,029,000USD5,334,000USD5,095,000USD4,339,245USD3,046,466USD2,533,593USD3,532,326USD
    Total Liab146,922,000USD139,660,000USD193,976,000USD196,487,000USD135,080,158USD119,423,968USD100,897,576USD69,106,083USD
    Total Stockholder Equity477,320,000USD349,018,000USD135,206,000USD151,974,000USD141,172,566USD88,249,426USD26,193,149USD19,770,438USD
    Other Current Liab43,113,000USD30,481,000USD32,919,000USD24,990,000USD17,214,988USD8,365,143USD4,481,395USD3,491,869USD
    Common Stock24,000USD24,000USD23,000USD22,000USD19,581USD10,490USD5,932USD4,635USD
    Capital Stock24,000USD24,000USD23,000USD22,182USD19,581USD10,490USD5,932USD4,635USD
    Retained Earnings-161,653,000USD-308,583,000USD-506,256,000USD-478,017,000USD-412,112,721USD-340,465,103USD-264,716,555USD-216,437,238USD
    Good Will3,530,000USD3,530,000USD3,530,000USD3,530,000USD3,529,509USD3,529,509USD3,529,509USD3,529,509USD
    Cash87,630,000USD103,147,000USD51,352,000USD86,522,000USD51,089,118USD55,921,152USD26,752,135USD22,754,852USD
    Cash And Short Term Investments87,630,000USD103,147,000USD51,352,000USD86,522,000USD51,089,118USD55,921,152USD26,752,135USD22,754,852USD
    Total Current Assets466,512,000USD331,410,000USD257,013,000USD270,402,000USD208,729,311USD153,740,507USD85,820,381USD44,529,625USD
    Total Current Liabilities69,541,000USD55,542,000USD49,806,000USD39,267,000USD30,378,315USD19,947,367USD14,027,893USD9,625,046USD
    Current Deferred Revenue1,405,000USD143,000USD182,000USD143,000USD142,834USD142,834USD142,834USD142,834USD
    Net Debt-7,745,000USD-21,031,000USD90,066,000USD67,920,000USD51,830,593USD41,747,547USD57,978,515USD21,469,225USD
    Short Term Debt3,909,000USD1,218,000USD1,045,000USD905,000USD591,084USD365,682USD229,073USD59,966USD
    Short Long Term Debt2,813,000USD———————
    Short Long Term Debt Total79,885,000USD82,116,000USD141,418,000USD154,442,000USD102,919,711USD97,668,699USD84,730,650USD44,224,077USD
    Long Term Debt69,330,000USD72,337,000USD130,594,000USD142,833,063USD94,866,239USD92,968,866USD68,291,163USD29,200,830USD
    Net Receivables158,429,000USD49,999,000USD27,421,000USD15,505,000USD28,576,857USD13,237,290USD3,469,919USD1,392,441USD
    Inventory206,465,000USD170,235,000USD172,906,000USD163,280,000USD124,724,091USD81,535,599USD53,064,734USD18,616,169USD
    Accounts Payable22,519,000USD20,219,000USD15,660,000USD13,229,000USD12,429,409USD11,073,708USD9,174,591USD5,900,394USD
    Property Plant Equipment Net71,707,000USD63,341,000USD63,470,000USD68,746,000USD58,197,732USD45,852,281USD32,986,346USD30,115,730USD
    Property Plant Equipment Gross110,055,000USD96,893,000USD90,207,000USD58,261,481USD50,935,074USD45,852,281USD31,741,317USD30,115,730USD
    Common Stock Shares Outstanding244,904,640shares243,342,000shares223,977,315shares197,874,895shares139,578,538shares86,145,052shares54,348,136shares45,188,899shares
    Non Current Assets Total157,730,000USD157,268,000USD72,169,000USD78,059,000USD67,523,413USD53,932,887USD41,270,344USD44,346,896USD
    Non Current Liabilities Total77,381,000USD84,118,000USD144,170,000USD157,220,000USD104,701,843USD99,476,601USD86,869,683USD59,481,037USD
    Non Currrent Assets Other8,600,000USD5,657,000USD4,670,000USD4,770,000USD4,067,404USD2,106,976USD1,595,015USD6,697,245USD
    Net Working Capital396,971,000USD275,868,000USD207,207,000USD231,134,841USD178,350,996USD133,793,140USD71,792,488USD34,904,579USD
    Unclassified Non Current Assets73,261,000USD84,280,000USD—-4,770,246USD-4,067,404USD-6,366,167USD-2,840,044USD-6,697,245USD
    Unclassified Current Liabilities-4,218,000USD3,481,000USD——————
    Unclassified Non Current Liabilities8,051,000USD10,108,000USD11,469,000USD8,852,998USD7,065,037USD-2,167,131,151USD-1,065,745USD-17,927,863USD
    Unclassified Equity638,925,000USD657,553,000USD641,416,000USD629,946,818USD553,246,125USD428,693,549USD296,622,796USD239,619,438USD
    Non Current Liabilities Other—1,673,000USD2,107,000USD1,850,454USD397,351USD54,886USD15,014,627USD27,756,762USD
    Other Assets——1USD4,770,246USD4,067,404USD6,366,167USD2,840,044USD6,697,245USD
    Other Liab———3,683,485USD2,373,216USD2,173,584,000USD2,368,106USD18,046,943USD
    Accumulated Other Comprehensive Income———0USD——-5,724,956USD-3,421,032USD
    Net Tangible Assets———151,974,215USD141,172,566USD82,275,796,000USD19,504,166USD12,236,517USD
    Deferred Long Term Liab——————2,261,532USD2,404,365USD
    Unclassified Current Assets———————-1,766,163USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income45,328,000USD49,379,000USD36,429,000USD34,218,000USD26,904,000USD111,896,000USD35,909,000USD32,061,999USD
    Depreciation1,839,000USD2,046,000USD2,023,000USD2,058,000USD1,969,000USD1,944,000USD1,940,000USD2,274,000USD
    Stock Based Compensation6,329,000USD5,392,000USD5,047,000USD4,963,000USD4,624,000USD5,433,000USD3,179,000USD2,863,000USD
    Other Non Cash Items-7,783,000USD170,000USD2,311,000USD1,284,000USD154,000USD-82,780,000USD224,000USD-1,891,000USD
    Change To Account Receivables22,567,000USD-20,756,000USD-27,948,000USD-10,313,000USD-49,413,000USD141,000USD-20,027,000USD19,508,000USD
    Change To Inventory-15,633,000USD-9,798,000USD-5,203,000USD-19,276,000USD-1,953,000USD1,566,000USD8,009,000USD-2,077,999USD
    Change In Working Capital9,244,000USD-22,520,000USD-37,320,000USD-23,004,000USD-56,751,000USD13,723,000USD-16,224,000USD10,338,001USD
    Total Cash From Operating Activities58,249,000USD35,639,000USD13,293,000USD21,139,000USD-19,675,000USD50,216,000USD25,028,000USD45,646,000USD
    Capital Expenditures-2,543,000USD-1,084,000USD-14,368,000USD-2,422,000USD-4,701,000USD-2,757,000USD-1,056,000USD-2,065,999USD
    Free Cash Flow55,706,000USD34,555,000USD-1,075,000USD18,717,000USD-24,376,000USD47,459,000USD23,972,000USD43,580,000USD
    Total Cashflows From Investing Activities2,404,000USD-276,000USD-14,368,000USD-2,527,000USD-4,720,000USD-2,750,000USD-1,098,000USD-2,365,000USD
    Net Borrowings124,531,000USD-469,000USD-469,000USD0USD0USD-30,000,000USD-30,000,000USD—
    Total Cash From Financing Activities-10,130,000USD-9,118,000USD-27,825,000USD48,000USD-7,127,000USD-31,026,000USD-25,467,000USD-362,000USD
    Sale Purchase Of Stock-130,191,000USD-8,902,000USD-23,038,000USD—-7,228,000USD-644,000USD3,169,000USD-693,000USD
    Change In Cash50,523,000USD26,245,000USD-28,900,000USD18,660,000USD-31,522,000USD16,440,000USD-1,537,000USD42,919,000USD
    Begin Period Cash Flow87,630,000USD61,385,000USD90,285,000USD71,625,000USD103,147,000USD86,707,000USD88,244,000USD45,325,000USD
    End Period Cash Flow138,153,000USD87,630,000USD61,385,000USD90,285,000USD71,625,000USD103,147,000USD86,707,000USD88,244,000USD
    Other Cashflows From Financing Activities-5,058,000USD-1,195,000USD-1,902,000USD-1,566,000USD101,000USD-382,000USD-1,158,000USD331,000USD
    Unclassified Operating Cash Flow3,292,000USD1,172,000USD4,803,000USD1,620,000USD3,425,000USD———
    Unclassified Investing Cash Flow4,947,000USD—14,368,000USD2,527,000USD4,720,000USD2,750,000USD1,412,000USD2,365,000USD
    Other Cashflows From Investing Activities—-192,000USD—-105,000USD-19,000USD7,000USD-356,000USD-299,001USD
    Unclassified Financing Cash Flow—1,448,000USD-2,416,000USD1,614,000USD——2,522,000USD—
    Investments——-14,368,000USD-2,527,000USD-4,720,000USD-2,750,000USD-1,098,000USD-2,365,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income146,930,000USD197,673,000USD-28,239,000USD-65,903,950USD-71,647,618USD-75,748,548USD-48,279,317USD-65,743,445USD
    Depreciation8,096,000USD8,045,000USD8,332,000USD7,113,369USD5,495,502USD3,942,292USD3,258,148USD3,446,398USD
    Stock Based Compensation20,026,000USD13,616,000USD6,187,000USD5,215,000USD3,488,000USD2,855,122USD2,650,777USD2,223,288USD
    Other Non Cash Items3,919,000USD2,157,000USD32,643,000USD12,353,058USD1,754,539USD1,639,594USD-320,341USD961,327USD
    Change To Account Receivables-108,430,000USD-22,578,000USD-11,916,000USD13,071,809USD-15,339,567USD-9,767,371USD-2,077,478USD2,487,713USD
    Change To Inventory-36,230,000USD2,671,000USD-9,626,000USD-38,555,957USD-43,188,489USD-28,470,864USD-34,650,132USD-5,987,988USD
    Change In Working Capital-139,595,000USD-18,539,000USD-10,123,000USD-18,285,265USD-51,680,419USD-33,781,318USD-33,502,771USD-3,688,440USD
    Total Cash From Operating Activities50,396,000USD118,672,000USD8,800,000USD-59,508,257USD-112,368,982USD-102,002,958USD-76,193,504USD-62,678,682USD
    Capital Expenditures-22,575,000USD-8,575,000USD-4,981,000USD-13,911,171USD-13,511,258USD-12,726,680USD-3,811,838USD-2,095,600USD
    Free Cash Flow27,821,000USD110,097,000USD3,819,000USD-73,419,428USD-125,880,240USD-114,729,638USD-80,005,342USD-64,774,282USD
    Total Cashflows From Investing Activities-21,891,000USD-8,575,000USD-4,981,000USD-13,911,171USD-13,511,258USD-12,724,680USD-3,811,838USD-2,095,600USD
    Net Borrowings-938,000USD-60,000,000USD-23,601,000USD48,967,072USD-34,299USD13,517,932USD34,290,489USD-36,278USD
    Total Cash From Financing Activities-44,022,000USD-58,302,000USD-38,989,000USD108,851,852USD121,048,206USD143,896,655USD80,002,625USD42,921,560USD
    Sale Purchase Of Stock-31,940,000USD—-1,415,000USD-2,898,840USD-61,598USD131,208,723USD48,472,136USD42,957,838USD
    Change In Cash-15,517,000USD51,795,000USD-35,170,000USD35,432,424USD-4,832,034USD29,169,017USD-2,717USD-21,852,722USD
    Begin Period Cash Flow103,147,000USD51,352,000USD86,522,000USD51,089,118USD55,921,152USD26,752,135USD26,754,852USD48,607,574USD
    End Period Cash Flow87,630,000USD103,147,000USD51,352,000USD86,521,542USD51,089,118USD55,921,152USD26,752,135USD26,754,852USD
    Other Cashflows From Investing Activities-316,000USD-349,000USD-210,000USD——2,000USD——
    Other Cashflows From Financing Activities-11,891,000USD-5,796,000USD-13,973,000USD-7,507,000USD-62,000USD-816,568USD-10,864,480USD13,007USD
    Unclassified Operating Cash Flow11,020,000USD-84,280,000USD——————
    Investments—-8,575,000USD-7,322,307USD-13,911,171USD-13,511,258USD-12,724,680USD-3,811,838USD-2,095,600USD
    Issuance Of Capital Stock—0USD0USD64,645,289USD121,144,103USD131,195,291USD48,397,088USD42,944,831USD
    Unclassified Investing Cash Flow—8,924,000USD7,532,307USD13,911,171USD13,511,258USD12,724,680USD3,811,838USD2,095,600USD
    Unclassified Financing Cash Flow—7,494,000USD—73,189,460USD121,267,701USD—8,104,480USD—
    Change To Liabilities———7,832,315USD9,915,621USD1,899,115USD3,890,039USD560,938USD
    Dividends Paid———-2,898,840USD-61,598USD———
    Cash And Cash Equivalents Changes———35,432,424USD-4,832,034USD29,169,017USD-2,717USD-21,852,722USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q2 2026Quarterly · 2026-06-30GeographyInternational1,077,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30GeographyUnited States123,318,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30SegmentADMABio Manufacturing123,637,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30SegmentPlasma Collection Centers723,000USDDisclosure
    Q1 2026Quarterly · 2026-03-31GeographyInternational1,068,000USD0001140361-26-019336
    Q1 2026Quarterly · 2026-03-31GeographyUnited States113,425,000USD0001140361-26-019336
    Q1 2026Quarterly · 2026-03-31SegmentADMABio Manufacturing113,741,000USD0001140361-26-019336
    Q1 2026Quarterly · 2026-03-31SegmentPlasma Collection Centers716,000USD0001140361-26-019336
    Q4 2025Quarterly · 2025-12-31GeographyInternational1,788,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31GeographyUnited States137,375,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31SegmentADMABio Manufacturing123,291,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31SegmentPlasma Collection Centers15,980,000USDLegacy provider
    FY 2025Yearly · 2025-12-31GeographyInternational6,106,000USD0001140361-26-006815
    FY 2025Yearly · 2025-12-31GeographyUnited States504,067,000USD0001140361-26-006815
    FY 2025Yearly · 2025-12-31SegmentADMABio Manufacturing493,143,000USD0001140361-26-006815
    FY 2025Yearly · 2025-12-31SegmentPlasma Collection Centers17,030,000USD0001140361-26-006815
    Q3 2025Quarterly · 2025-09-30GeographyInternational246,000USD0001140361-25-040578
    Q3 2025Quarterly · 2025-09-30GeographyUnited States133,978,000USD0001140361-25-040578
    Q3 2025Quarterly · 2025-09-30SegmentADMABio Manufacturing134,188,000USD0001140361-25-040578
    Q3 2025Quarterly · 2025-09-30SegmentPlasma Collection Centers0USD0001140361-25-040578
    Q2 2025Quarterly · 2025-06-30GeographyInternational0USD0001140361-25-029177
    Q2 2025Quarterly · 2025-06-30GeographyUnited States121,984,000USD0001140361-25-029177
    Q2 2025Quarterly · 2025-06-30SegmentADMABio Manufacturing121,948,000USD0001140361-25-029177
    Q2 2025Quarterly · 2025-06-30SegmentPlasma Collection Centers0USD0001140361-25-029177
    Q1 2025Quarterly · 2025-03-31GeographyInternational4,072,000USD0001140361-26-019336
    Q1 2025Quarterly · 2025-03-31GeographyUnited States110,730,000USD0001140361-26-019336
    Q1 2025Quarterly · 2025-03-31SegmentADMABio Manufacturing113,716,000USD0001140361-26-019336
    Q1 2025Quarterly · 2025-03-31SegmentPlasma Collection Centers1,050,000USD0001140361-26-019336
    Q4 2024Quarterly · 2024-12-31GeographyInternational2,866,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31GeographyUnited States114,683,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31SegmentADMABio Manufacturing111,934,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31SegmentPlasma Collection Centers5,723,000USDLegacy provider
    FY 2024Yearly · 2024-12-31GeographyInternational16,306,000USD0001140361-26-006815
    FY 2024Yearly · 2024-12-31GeographyUnited States410,148,000USD0001140361-26-006815
    FY 2024Yearly · 2024-12-31SegmentADMABio Manufacturing415,949,000USD0001140361-26-006815
    FY 2024Yearly · 2024-12-31SegmentPlasma Collection Centers10,505,000USD0001140361-26-006815
    Q3 2024Quarterly · 2024-09-30GeographyInternational5,091,000USD0001140361-25-040578
    Q3 2024Quarterly · 2024-09-30GeographyUnited States114,748,000USD0001140361-25-040578
    Q3 2024Quarterly · 2024-09-30SegmentADMABio Manufacturing113,088,000USD0001140361-24-045693
    Q3 2024Quarterly · 2024-09-30SegmentCorporate36,000USD0001140361-24-045693
    Q3 2024Quarterly · 2024-09-30SegmentPlasma Collection Centers6,715,000USD0001140361-24-045693
    FY 2023Yearly · 2023-12-31GeographyInternational13,334,000USD0001140361-26-006815
    FY 2023Yearly · 2023-12-31GeographyUnited States244,881,000USD0001140361-26-006815
    FY 2023Yearly · 2023-12-31SegmentADMABio Manufacturing249,738,000USD0001140361-24-010147
    FY 2023Yearly · 2023-12-31SegmentCorporate143,000USD0001140361-24-010147
    FY 2023Yearly · 2023-12-31SegmentPlasma Collection Centers8,334,000USD0001140361-24-010147
    FY 2022Yearly · 2022-12-31GeographyInternational7,653,000USD0001140361-25-009257
    FY 2022Yearly · 2022-12-31GeographyUnited States146,427,000USD0001140361-25-009257
    FY 2022Yearly · 2022-12-31SegmentADMABio Manufacturing144,070,000USD0001140361-24-010147
    FY 2022Yearly · 2022-12-31SegmentCorporate143,000USD0001140361-24-010147
    FY 2022Yearly · 2022-12-31SegmentPlasma Collection Centers9,867,000USD0001140361-24-010147
    FY 2022Yearly · 2022-12-31ProductLicense And Service142,834USD0001140361-23-013467
    FY 2022Yearly · 2022-12-31ProductProduct153,936,858USD0001140361-23-013467
    Q4 2022Quarterly · 2022-12-31ProductLicense And Service35,709USDLegacy provider
    Q4 2022Quarterly · 2022-12-31ProductProduct49,945,746USDLegacy provider
    Q3 2022Quarterly · 2022-09-30ProductLicense And Service35,708USD0001140361-22-040738
    Q3 2022Quarterly · 2022-09-30ProductProduct41,054,429USD0001140361-22-040738
    Q2 2022Quarterly · 2022-06-30ProductLicense And Service35,709USD0001140361-22-029116
    Q2 2022Quarterly · 2022-06-30ProductProduct33,869,298USD0001140361-22-029116
    Q1 2022Quarterly · 2022-03-31ProductLicense And Service35,708USD0001140361-22-018668
    Q1 2022Quarterly · 2022-03-31ProductProduct29,067,385USD0001140361-22-018668
    FY 2021Yearly · 2021-12-31GeographyInternational10,317,000USD0001140361-24-010147
    FY 2021Yearly · 2021-12-31GeographyUnited States70,626,000USD0001140361-24-010147
    FY 2021Yearly · 2021-12-31SegmentADMABio Manufacturing74,936,000USD0001140361-24-010147
    FY 2021Yearly · 2021-12-31SegmentCorporate143,000USD0001140361-24-010147
    FY 2021Yearly · 2021-12-31SegmentPlasma Collection Centers5,864,000USD0001140361-24-010147
    FY 2021Yearly · 2021-12-31ProductLicense And Service142,834USD0001140361-23-013467
    FY 2021Yearly · 2021-12-31ProductProduct80,799,791USD0001140361-23-013467
    Q4 2021Quarterly · 2021-12-31ProductLicense And Service35,709USDLegacy provider
    Q4 2021Quarterly · 2021-12-31ProductProduct26,347,158USDLegacy provider
    Q3 2021Quarterly · 2021-09-30ProductLicense And Service35,708USD0001140361-22-040738
    Q3 2021Quarterly · 2021-09-30ProductProduct20,644,842USD0001140361-22-040738
    Q2 2021Quarterly · 2021-06-30ProductLicense And Service35,709USD0001140361-22-029116
    Q2 2021Quarterly · 2021-06-30ProductProduct17,794,881USD0001140361-22-029116
    Q1 2021Quarterly · 2021-03-31ProductLicense And Service35,708USD0001140361-22-018668
    Q1 2021Quarterly · 2021-03-31ProductProduct16,012,910USD0001140361-22-018668
    FY 2020Yearly · 2020-12-31GeographyInternational5,667,539USD0001140361-22-011030
    FY 2020Yearly · 2020-12-31GeographyUnited States36,552,244USD0001140361-22-011030
    FY 2020Yearly · 2020-12-31SegmentADMABio Manufacturing36,673,287USD0001140361-22-011030
    FY 2020Yearly · 2020-12-31SegmentCorporate142,834USD0001140361-22-011030
    FY 2020Yearly · 2020-12-31SegmentPlasma Collection Centers5,403,662USD0001140361-22-011030
    FY 2020Yearly · 2020-12-31ProductLicense And Service142,834USD0001140361-22-011030
    FY 2020Yearly · 2020-12-31ProductProduct42,076,949USD0001140361-22-011030
    FY 2019Yearly · 2019-12-31SegmentConsolidated — Adma Biomanufacturing22,176,699USD0001193805-21-000411
    FY 2019Yearly · 2019-12-31SegmentConsolidated — Corporate142,834USD0001193805-21-000411
    FY 2019Yearly · 2019-12-31SegmentConsolidated — Plasma Collection Center7,029,550USD0001193805-21-000411
    FY 2018Yearly · 2018-12-31SegmentAdma Biomanufacturing6,797,548USD0001193805-20-000348
    FY 2018Yearly · 2018-12-31SegmentCorporate142,834USD0001193805-20-000348
    FY 2018Yearly · 2018-12-31SegmentPlasma Collection Center10,044,908USD0001193805-20-000348

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.